Regulatory Frameworks for Human Gene Editing: A Systematic Literature Review
Abstract views: 32
/ 
PDF downloads: 25
DOI:
https://doi.org/10.59022/ijlp.333Keywords:
Gene Editing, CRISPR-Cas9, Human Genome, Regulatory Framework, Bioethics, Germline ModificationAbstract
Human gene editing technologies, especially CRISPR-Cas9, have advanced rapidly, raising complex regulatory, ethical, and scientific issues. This study reviews 47 peer-reviewed articles published between 2015 and 2025, following PRISMA 2020 guidelines. The analysis reveals major empirical, theoretical, methodological, and practical gaps in governance. It notes a lack of global harmonisation, weak ethical oversight, and inconsistent national policies that obstruct responsible innovation. Developing countries often lack enforceable guidelines, while developed nations use varied regulatory frameworks, leading to fragmentation. The study recommends a shared, participatory regulatory model, stronger international cooperation, and better integration of bioethics into policy-making. These steps are vital to ensure fair access, protect human dignity, and build public trust as gene editing moves into clinical and societal applications.
References
Almeida, M., & Ranisch, R. (2022). Beyond safety: Mapping the ethical debate on heritable genome editing interventions. Humanities and Social Sciences Communications, 9(1), 139. University of Tübingen. https://doi.org/10.1057/s41599-022-01147-y DOI: https://doi.org/10.1057/s41599-022-01147-y
Barlevy, D., Juengst, E., Kahn, J., Moreno, J., Lambert, L., Charo, A., Chneiweiss, H., Farooque, M., Guston, D. H., Hyun, I., Knoepfler, P. S., Selin, C., Wilbanks, R., Zaghlula, M., & Scott, C. T. (2024). Governing with public engagement: An anticipatory approach to human genome editing. Science and Public Policy, 51(4), 680–691. Baylor College of Medicine. https://doi.org/10.1093/scipol/scae010 DOI: https://doi.org/10.1093/scipol/scae010
Berlincourt, J., Gächter, S., Vayena, E., & Ormond, K. E. (2024). Experts’ perspectives on human gene editing in Switzerland. Journal of Community Genetics, 16(1), 83–90. Health Sciences and Technologies Department ETH Zurich. https://doi.org/10.1007/s12687-024-00757-0 DOI: https://doi.org/10.1007/s12687-024-00757-0
Cavaliere, G., Devolder, K., & Giubilini, A. (2019). Regulating Genome Editing: For an Enlightened Democratic Governance. Cambridge Quarterly of Healthcare Ethics, 28(1), 76–88. University of Edinburgh. https://doi.org/10.1017/S0963180118000403 DOI: https://doi.org/10.1017/S0963180118000403
Chen, Y., & Luo, X. (2024). Reflection on Gene Editing from the Perspective of Biopolitics. NanoEthics, 18(1), 4. Shanghai Normal University. https://doi.org/10.1007/s11569-023-00451-4 DOI: https://doi.org/10.1007/s11569-023-00451-4
Cohen, I. G., Sherkow, J. S., & Adashi, E. Y. (2022). Handle with Care: The WHO Report on Human Genome Editing. Hastings Center Report, 52(2), 10–14. Harvard Law School. https://doi.org/10.1002/hast.1350 DOI: https://doi.org/10.1002/hast.1350
Conditi, N. (2022). Regulating Heritable Human Genome Editing: Drawing the Line between Legitimate and Controversial Use. European Journal of Health Law, 29(3–5), 435–457. University of Bologna. https://doi.org/10.1163/15718093-bja10080 DOI: https://doi.org/10.1163/15718093-bja10080
De Miguel Beriain, I. (2017). Legal Issues Regarding Gene Editing at the Beginning of Life: An EU Perspective. Regenerative Medicine, 12(6), 669–679. University of the Basque Country. https://doi.org/10.2217/rme-2017-0033 DOI: https://doi.org/10.2217/rme-2017-0033
Discussion on Human Gene Editing Technology from the Perspective of Ethics and Law. (2021). Academic Journal of Humanities & Social Sciences, 4(11). University of Washington. https://doi.org/10.25236/AJHSS.2021.041117 DOI: https://doi.org/10.25236/AJHSS.2021.041117
Farasat, I., & Salis, H. M. (2016). A Biophysical Model of CRISPR/Cas9 Activity for Rational Design of Genome Editing and Gene Regulation. PLOS Computational Biology, 12(1), e1004724. Pennsylvania State University. https://doi.org/10.1371/journal.pcbi.1004724 DOI: https://doi.org/10.1371/journal.pcbi.1004724
Feeney, O., Cockbain, J., & Sterckx, S. (2021). Ethics, Patents and Genome Editing: A Critical Assessment of Three Options of Technology Governance. Frontiers in Political Science, 3, 731505. University of Tübingen. https://doi.org/10.3389/fpos.2021.731505 DOI: https://doi.org/10.3389/fpos.2021.731505
Gazina, N. I. (2024). International Legal Approaches to the Issue of Admissibility of the Use of Genomic Technologies in Medicine. Actual Problems of Russian Law, 19(6), 177–189. Kutafin Moscow State Law University (MSAL). https://doi.org/10.17803/1994-1471.2024.163.6.177-189 DOI: https://doi.org/10.17803/1994-1471.2024.163.6.177-189
Hawkes, N. (2015). UK’s approval of mitochondrial donation shows how decisions on gene editing can be made. BMJ, h6745. British Medical Journal. https://doi.org/10.1136/bmj.h6745 DOI: https://doi.org/10.1136/bmj.h6745
Hayenhjelm, M., & Nordlund, C. (2025). The Risks and Ethics of Human Gene Editing: A Philosophical Guide to the Arguments: Vol. Qualitative. Springer Fachmedien Wiesbaden; Umeå University. https://doi.org/10.1007/978-3-658-46979-5 DOI: https://doi.org/10.1007/978-3-658-46979-5
Iacomussi, S. (2019). Regulating genome editing technologies: A comparison of expert recommendations in the U.K. and in the U.S.A. Emerging Topics in Life Sciences, 3(6), 701–705. University of Edinburgh. https://doi.org/10.1042/ETLS20180101 DOI: https://doi.org/10.1042/ETLS20180101
Kim, N.-K. (2017). Gene-Editing: Interpretation of Current Law and Legal Policy. Development & Reproduction, 21(3), 343–349. Sungshin University. https://doi.org/10.12717/DR.2017.21.3.343 DOI: https://doi.org/10.12717/DR.2017.21.3.343
Knoppers, B. M., Isasi, R., Caulfield, T., Kleiderman, E., Bedford, P., Illes, J., Ogbogu, U., Ravitsky, V., & Rudnicki, M. (2017). Human gene editing: Revisiting Canadian policy. npj Regenerative Medicine, 2(1), 3, s41536-017-0007–2. McGill University. https://doi.org/10.1038/s41536-017-0007-2 DOI: https://doi.org/10.1038/s41536-017-0007-2
Koščík, M., & Vladíková, E. (2023). The Object-Based and Process-Based Regulation of Genome Editing. In S. Slokenberga, T. Minssen, & A. Nordberg (Eds.), Governing, Protecting, and Regulating the Future of Genome Editing: Vol. Mixed Method (pp. 160–179). Brill | Nijhoff; Masaryk University. https://doi.org/10.1163/9789004526136_009 DOI: https://doi.org/10.1163/9789004526136_009
Kritikos, M. (2018). Governing Gene Editing in the European Union: Legal and Ethical Considerations. In Z. Koporc (Ed.), Advances in Research Ethics and Integrity (Vol. 4, pp. 99–114). Emerald Publishing Limited; Vrije Universiteit Brussel. https://www.emerald.com/insight/content/doi/10.1108/S2398-601820180000004007/full/html DOI: https://doi.org/10.1108/S2398-601820180000004007
Lange, V., & Kappel, K. (2022). CRISPR Gene-Therapy: A Critical Review of Ethical Concerns and a Proposal for Public Decision-Making. Canadian Journal of Bioethics, 5(2), 78. University of Copenhagen. https://doi.org/10.7202/1089787ar DOI: https://doi.org/10.7202/1089787ar
Lei, R., & Qiu, R. (2020). Ethical and regulatory issues in human gene editing: Chinese perspective. Biotechnology and Applied Biochemistry, 67(6), 880–891. University of Science and Technology. https://doi.org/10.1002/bab.2032 DOI: https://doi.org/10.1002/bab.2032
Mahalatchimy, A., Lau, P. L., Li, P., & Flear, M. L. (2021). Framing and legitimating EU legal regulation of human gene-editing technologies: Key facets and functions of an imaginary. Journal of Law and the Biosciences, 8(2), lsaa080. Aix-Marseille University. https://doi.org/10.1093/jlb/lsaa080 DOI: https://doi.org/10.1093/jlb/lsaa080
Minari, J., Shinomiya, N., Takashima, K., & Yoshizawa, G. (2022). Contiguous Governance of Synchronic and Diachronic Changes for the Use of Genome Editing Technologies. Frontiers in Political Science, 4. Kyoto University. https://doi.org/10.3389/fpos.2022.825496 DOI: https://doi.org/10.3389/fpos.2022.825496
Mourby, M., & Morrison, M. (2020). Gene therapy regulation: Could in-body editing fall through the net? European Journal of Human Genetics, 28(7), 979–981. University of Oxford. https://doi.org/10.1038/s41431-020-0607-y DOI: https://doi.org/10.1038/s41431-020-0607-y
Nekoteneva, M. V., & Ponomareva, D. V. (2023). Legal Regulation of Patenting the Results of Genomic Research at the Global, Regional and National Level. Lex Genetica, 2(1), 61–78. Kutafin Moscow State Law University (MSAL). https://doi.org/10.17803/lexgen-2023-2-1-61-78 DOI: https://doi.org/10.17803/lexgen-2023-2-1-61-78
Nelson, J. P., Selin, C. L., & Scott, C. T. (2021). Toward anticipatory governance of human genome editing: A critical review of scholarly governance discourse. Journal of Responsible Innovation, 8(3), 382–420. Arizona State University. https://doi.org/10.1080/23299460.2021.1957579 DOI: https://doi.org/10.1080/23299460.2021.1957579
Niazi, S. K. (2023). Gene Editing: The Regulatory Perspective. Encyclopedia, 3(4), 1345–1357. University of Illinois. https://doi.org/10.3390/encyclopedia3040096 DOI: https://doi.org/10.3390/encyclopedia3040096
Nicol, D., Niemeyer, S., Paxton, R., & Rudge, C. (2023). Points to consider in the development of national human genome editing policy. Cambridge Prisms: Precision Medicine, 1, e23. University of Tasmania. https://doi.org/10.1017/pcm.2023.11 DOI: https://doi.org/10.1017/pcm.2023.11
Olaghere, J., Williams, D. A., Farrar, J., Büning, H., Calhoun, C., Ho, T., Inamdar, M. S., Liu, D., Makani, J., Nyarko, K., Ruiz, S., Tisdale, J., McCune, J. M., Boadi, E., & Reagan-Udall Foundation for the FDA. (2025). Scientific Advancements in Gene Therapies: Opportunities for Global Regulatory Convergence. Biomedicines, 13(3), 758. Udall Foundation for the FDA. https://doi.org/10.3390/biomedicines13030758 DOI: https://doi.org/10.3390/biomedicines13030758
Ollanazarova Mamura Muzaffarovna. (2023). Analyzing the Legal Labyrinth: Current Trends in Genetic Research and Their Legal Perspectives. International Journal of Law and Policy, 1(5). Tashkent State University of Law. https://doi.org/10.59022/ijlp.84 DOI: https://doi.org/10.59022/ijlp.84
on behalf of the Public and Professional Policy Committee of the European Society of Human Genetics, Howard, H. C., Van El, C. G., Forzano, F., Radojkovic, D., Rial-Sebbag, E., De Wert, G., Borry, P., & Cornel, M. C. (2018). One small edit for humans, one giant edit for humankind? Points and questions to consider for a responsible way forward for gene editing in humans. European Journal of Human Genetics, 26(1), 1–11. Uppsala University. https://doi.org/10.1038/s41431-017-0024-z DOI: https://doi.org/10.1038/s41431-017-0024-z
Pestrikova, A. (2022). Perspectives of genome editing in humans: Risks, problems and legal regulation. Медицинская этика, 2022(2). Toliatti State University. https://doi.org/10.24075/medet.2022.048 DOI: https://doi.org/10.24075/medet.2022.048
Rabuma, T., Moronta-Barrios, F., & Craig, W. (2024). Navigating biosafety regulatory frameworks for genetic engineering in Africa: A focus on genome editing and gene drive technologies. Frontiers in Bioengineering and Biotechnology, 12. Wolkite University. https://doi.org/10.3389/fbioe.2024.1483279 DOI: https://doi.org/10.3389/fbioe.2024.1483279
Rueda, J., Segers, S., Hopster, J., Kudlek, K., Liedo, B., Marchiori, S., & Danaher, J. (2025). Anticipatory gaps challenge the public governance of heritable human genome editing. Journal of Medical Ethics, 51(5), jme-2023-109801. University of Basque Country. https://doi.org/10.1136/jme-2023-109801 DOI: https://doi.org/10.1136/jme-2023-109801
Saluja, M., & Khushi, K. (2024). Ethical Contemplations In Indian Science Fiction: The Case Of Gene Editing. Vantage: Journal of Thematic Analysis, 5(2), 43–56. University of Delhi. https://doi.org/10.52253/vjta.2024.v05i02.05 DOI: https://doi.org/10.52253/vjta.2024.v05i02.05
Schacker, M., & Seimetz, D. (2019). From fiction to science: Clinical potentials and regulatory considerations of gene editing. Clinical and Translational Medicine, 8(1), e27. Biopharma Excellence GmbH. https://doi.org/10.1186/s40169-019-0244-7 DOI: https://doi.org/10.1186/s40169-019-0244-7
Schweikart, S. J. (2019). What Is Prudent Governance of Human Genome Editing. American Medical Association.
Shozi, B., & Thaldar, D. (2023). Promoting Equality in the Governance of Heritable Human Genome Editing through Ubuntu: Reflecting on a South African Public Engagement Study. The American Journal of Bioethics, 23(7), 43–49. University of KwaZulu-Natal. https://doi.org/10.1080/15265161.2023.2207524 DOI: https://doi.org/10.1080/15265161.2023.2207524
Slokenberga, S., Minssen, T., & Nordberg, A. (Eds.). (2023). Governing, Protecting, and Regulating the Future of Genome Editing: The Significance of ELSPI Perspectives: Vol. Qualitative. Brill | Nijhoff; Uppsala University. https://doi.org/10.1163/9789004526136 DOI: https://doi.org/10.1163/9789004526136
Sprink, T., & Wilhelm, R. (2024). Genome Editing in Biotech Regulations Worldwide. In A. Ricroch, D. Eriksson, D. Miladinović, J. Sweet, K. Van Laere, & E. Woźniak-Gientka (Eds.), A Roadmap for Plant Genome Editing: Vol. Qualitative (pp. 425–435). Springer Nature Switzerland; Leibniz Institute of Plant Genetics and Crop Plant Research. https://doi.org/10.1007/978-3-031-46150-7_25 DOI: https://doi.org/10.1007/978-3-031-46150-7_25
Thaldar, D., & Shozi, B. (2023). An imbalanced approach to governance? An analysis of the WHO’s position on human genome editing. Bioethics, 37(7), 656–661. University of KwaZulu‐Natal. https://doi.org/10.1111/bioe.13193 DOI: https://doi.org/10.1111/bioe.13193
Townsend, B. A. (2020). Human genome editing: How to prevent rogue actors. BMC Medical Ethics, 21(1), 95. University of KwaZulu-Natal. https://doi.org/10.1186/s12910-020-00527-w DOI: https://doi.org/10.1186/s12910-020-00527-w
Townsend, B., & Shozi, B. (2021). ALTERING THE HUMAN GENOME: MAPPING THE GENOME EDITING REGULATORY SYSTEM IN SOUTH AFRICA. Potchefstroom Electronic Law Journal, 24, 1–28. University of KwaZulu-Natal. https://doi.org/10.17159/1727-3781/2021/v24i0a9179 DOI: https://doi.org/10.17159/1727-3781/2021/v24i0a9179
Troitskaya, A. A., & Sharlovskiy, K. A. (2024). Human Genome Editing: Managing Technological Risks through Legal Means. Journal of Digital Technologies and Law, 2(3), 521–543. Lomonosov Moscow State University. https://doi.org/10.21202/jdtl.2024.27 DOI: https://doi.org/10.21202/jdtl.2024.27
Van Beers, B. C. (2020). Rewriting the human genome, rewriting human rights law? Human rights, human dignity, and human germline modification in the CRISPR era. Journal of Law and the Biosciences, 7(1), lsaa006. Vrije Universiteit Amsterdam. https://doi.org/10.1093/jlb/lsaa006 DOI: https://doi.org/10.1093/jlb/lsaa006
Yotova, R. (2020). REGULATING GENOME EDITING UNDER INTERNATIONAL HUMAN RIGHTS LAW. International and Comparative Law Quarterly, 69(3), 653–684. University of Cambridge. https://doi.org/10.1017/S0020589320000184 DOI: https://doi.org/10.1017/S0020589320000184
Yu, H., Xue, L., Barrangou, R., Chen, S., & Huang, Y. (2021). Toward inclusive global governance of human genome editing. Proceedings of the National Academy of Sciences, 118(47), e2118540118. Zhejiang University. https://doi.org/10.1073/pnas.2118540118 DOI: https://doi.org/10.1073/pnas.2118540118
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Kalani Fernando, Duminda De Silva, Asanka Ekanayake
This work is licensed under a Creative Commons Attribution 4.0 International License.
